Antibacterial Oxazolidinones Possessing a Novel C-5 Side Chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic Acid Amide (PF-00422602), a New Lead Compound

Antibacterial Oxazolidinones Possessing a Novel C-5 Side Chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic Acid Amide (PF-00422602), a New Lead Compound Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics Novel Substituted (Pyridin-3-yl)phenyloxazolidinones:  Antibacterial Agents with Reduced Activity against Monoamine Oxidase A and Increased Solubility Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure Potent Oxazolidinone Antibacterials with Heteroaromatic C-Ring Substructure Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives